These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12820393

  • 1. Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA).
    Braun JM, Blackwell CC, Weir DM, Beuth J.
    Anticancer Res; 2003; 23(2B):1349-52. PubMed ID: 12820393
    [Abstract] [Full Text] [Related]

  • 2. Mistletoe lectin-1 increases tumor necrosis factor-alpha release in lipopolysaccharide-stimulated whole blood via inhibition of interleukin-10 production.
    Boneberg EM, Hartung T.
    J Pharmacol Exp Ther; 2001 Sep; 298(3):996-1000. PubMed ID: 11504795
    [Abstract] [Full Text] [Related]

  • 3. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro.
    Thies A, Nugel D, Pfüller U, Moll I, Schumacher U.
    Toxicology; 2005 Feb 01; 207(1):105-16. PubMed ID: 15590126
    [Abstract] [Full Text] [Related]

  • 4. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U, Göthel D, Leng-Peschlow E.
    Anticancer Res; 2002 Feb 01; 22(3):1399-407. PubMed ID: 12168816
    [Abstract] [Full Text] [Related]

  • 5. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
    Gabius HJ, Gabius S, Joshi SS, Koch B, Schroeder M, Manzke WM, Westerhausen M.
    Planta Med; 1994 Feb 01; 60(1):2-7. PubMed ID: 8134410
    [Abstract] [Full Text] [Related]

  • 6. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V.
    J Biol Regul Homeost Agents; 1993 Feb 01; 7(1):1-6. PubMed ID: 8346712
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
    Kelter G, Schierholz JM, Fischer IU, Fiebig HH.
    Anticancer Res; 2007 Feb 01; 27(1A):223-33. PubMed ID: 17352237
    [Abstract] [Full Text] [Related]

  • 8. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
    Beuth J, Ko HL, Tunggal L, Steuer MK, Geisel J, Jeljaszewicz J, Pulverer G.
    In Vivo; 1993 Feb 01; 7(5):407-10. PubMed ID: 8110981
    [Abstract] [Full Text] [Related]

  • 9. Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines.
    Möckel B, Schwarz T, Zinke H, Eck J, Langer M, Lentzen H.
    Arzneimittelforschung; 1997 Oct 01; 47(10):1145-51. PubMed ID: 9368710
    [Abstract] [Full Text] [Related]

  • 10. No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro.
    Burger AM, Mengs U, Kelter G, Schüler JB, Fiebig HH.
    Anticancer Res; 2003 Oct 01; 23(5A):3801-6. PubMed ID: 14666680
    [Abstract] [Full Text] [Related]

  • 11. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
    Heiny BM, Beuth J.
    Anticancer Res; 1994 Oct 01; 14(3B):1339-42. PubMed ID: 8067703
    [Abstract] [Full Text] [Related]

  • 12. [Immunoactive action of mistletoe lectin-1 in relation to dose].
    Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G.
    Arzneimittelforschung; 1994 Nov 01; 44(11):1255-8. PubMed ID: 7848341
    [Abstract] [Full Text] [Related]

  • 13. [Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
    Mengs U, Witthohn K, Schwarz T, Lentzen H.
    Wien Med Wochenschr; 1999 Nov 01; 149(8-10):262-4. PubMed ID: 10483695
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J.
    Anticancer Drugs; 1997 Apr 01; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice.
    Stoffel B, Krämer K, Mayer H, Beuth J.
    Anticancer Res; 1997 Apr 01; 17(3C):1893-6. PubMed ID: 9216641
    [Abstract] [Full Text] [Related]

  • 16. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G, Jung ML, Frantz M, Anton R.
    Anticancer Drugs; 1997 Apr 01; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [Abstract] [Full Text] [Related]

  • 17. Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers.
    Wirtz PH, von Känel R, Kunz-Ebrecht S, Ehlert U, Fischer JE.
    Brain Behav Immun; 2004 Nov 01; 18(6):536-43. PubMed ID: 15331124
    [Abstract] [Full Text] [Related]

  • 18. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
    Stein GM, Pfüller U, Schietzel M.
    Anticancer Res; 1999 Nov 01; 19(4B):2925-8. PubMed ID: 10652574
    [Abstract] [Full Text] [Related]

  • 19. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
    Braun JM, Ko HL, Schierholz JM, Beuth J.
    Anticancer Res; 2002 Nov 01; 22(6C):4187-90. PubMed ID: 12553054
    [Abstract] [Full Text] [Related]

  • 20. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects.
    Huber R, Rostock M, Goedl R, Lüdtke R, Urech K, Klein R.
    J Soc Integr Oncol; 2006 Nov 01; 4(1):3-7. PubMed ID: 16737665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.